Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Generic: Depreotide
Depreotide is a synthetic peptide analogue of somatostatin, a hormone that inhibits the release of growth hormone and other hormones. It is primarily used in clinical research to investigate its potential in treating various conditions, including acromegaly, carcinoid tumors, and other neuroendocrine tumors. Its mechanism of action involves binding to somatostatin receptors, which leads to the suppression of hormone secretion.
Used primarily in clinical research for conditions like acromegaly and neuroendocrine tumors.
Outcome:
Additive effects, leading to severe hypoglycemia
Mechanism:
Both drugs inhibit growth hormone and insulin secretion.
Outcome:
Bradycardia
Mechanism:
Depreotide can slow heart rate, additive effect with calcium channel blockers.
Outcome:
Reduced absorption of Depreotide
Mechanism:
Antacids can alter gastric pH.
Most likely new formulation: sustained-release injectable (2026, 80% confidence)
Based on current clinical trial data and similar somatostatin analogues, there is a 70% likelihood of Depreotide gaining regulatory approval for specific indications within the next 5 years.
Somatostatin Analogue
Cyclic Peptide